Currently holds positions in Denali Therapeutics Inc and BridgeBio Pharma Inc
Position | Company | Period |
---|---|---|
Independent Director | Denali Therapeutics Inc | Nov. 6, 2018 - |
Independent Director | BridgeBio Pharma Inc | Dec. 1, 2019 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-08-15 | 2023-08-14 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
S Sale |
1,241
-14.5%
138.16171,454 USD |
1,241 -14.5% | 138.16 | 171,454 USD | |
2022-12-06 | 2022-12-02 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
S Sale |
420
-7.1%
154.6864,966 USD |
420 -7.1% | 154.68 | 64,966 USD | |
2022-08-09 | 2022-08-08 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
S Sale |
1,089
-15.6%
152.32165,879 USD |
1,089 -15.6% | 152.32 | 165,879 USD | |
2021-12-06 | 2021-12-02 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
S Sale |
417
-8.6%
121.3050,582 USD |
417 -8.6% | 121.30 | 50,582 USD |